Great post, Guts, and, BTW,  compliments on your use of color. The great success just won in achieving access to the Hong Kong market, should make it easier and quicker to gain access to the mainland market in China. This widening of the international limits of the Rapimeds distribution pattern is just  what is needed to implement SCRC's expansionary buildout. The company is being built up and built out day by day.